Microfluidic Device Systems Market in North America to Grow at Striking 21.70% CAGR from 2013 to 2019

There has been a recent release of a new report on the global microfluidic device systems market by Transparency Market Research (TMR). The report suggests that the global microfluidic device market is estimated to grow at a CAGR of 22.8% during the period of 2013 to 2019. The market, which was valued at US$1.5 bn in 2013, will reach US$5.2 bn in 2019.The report, which is titled “Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” provides a comprehensive study on the analysis of the microfluidic device market for the period from 2014 to 2019, wherein 2013 is considered as the base year for calculation. The report contains data related to the current market dynamics, trends, market drivers, restraints, and also the strategic developments propelling the global microfluidic device systems market.

The report states that the rising demand for microfluidic devices in proteomics and genomics, point of care testing, and miniaturization of chips are the chief driving forces behind the microfluidic device systems market’s growth. Another factor that could fuel the growth of the microfluidic device systems market is a change in the material mix, which would provide an opportunity to new market entrants. Conversely, strict regulations and standards for global affiliation of medical devices as well as high performance and consistency in quality of the devices are some of the factors limiting the growth of the microfluidic device systems market. Manufacturing issues such as surface chemistry and geometrical issues also account for the challenges faced by the microfluidic device systems market.

The report categorizes the global market for microfluidic device systems chiefly on the basis of four criteria: geography, industry, application, and materials used in the manufacturing process of microfluidic devices.

On the basis of application, the market for microfluidic devices is segmented into pharmaceutical and life sciences research, point of care testing, environment and industrial, clinical and veterinary diagnostics, and drug delivery. Of these, the largest segment of the microfluidic devices market is the veterinary and clinical diagnostic application segment.

Geographically, the microfluidic devices market is segmented into Asia, North America and Europe, wherein North America dominates the global microfluidic devices market, while Asia is a rapidly developing region for the microfluidic devices market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1561

On the basis of industry, the microfluidic devices market is segmented into in- vitro diagnostics, pharmaceuticals, and medical devices. Among these, in-vitro diagnostics is the largest industry and is estimated to reach US$3.3 bn in 2019.

The report profiles some of the prominent companies such as Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Becton Dickinson and Company, Agilent Technologies, Fluidigm Corporation, Bio-Rad Laboratories, and Johnson & Johnson, which are key players in the microfluidic devices market.

The market for microfluidics devices can be expected to rise as microfluidics is an evolving field with a huge potential commercially. With applications in various fields such as cell biology research, protein crystallization, and medicine, microfluidics will remain in the market due to its efficacy in the field of treatment.

Growing Demand for Actigraphy Systems Driving Sleep Apnea Diagnostic and Therapeutic Devices Market to Reach US$6.4 Bn by 2019

The global sleep apnea market is largely fragmented in nature having an establishment of big and emerging companies. Players such as ResMed, Inc., Philips Respironics, and Fisher & Paykel Healthcare are amongst the well-established players presenting an extensive range of sleep apnea products in the market. All these players are highly focused on providing consistent product innovation and novel technologies by carrying on extensive research and development for backing the newly launched product advancement processes. In addition, the skyrocketing demand for advanced technologies within sleep apnea devices market and the growing financing activities of upcoming companies may raise the threat from new entrants in this market in forthcoming years.

The global sleep apnea diagnostics and therapeutic devices market is predicted to touch US$ 6,437.6 mn by 2019. In terms of diagnostic devices, polysomnography (PSG) devices represented the top share in the market in the past and are predicted to touch US$788.7 mn by 2019. On the other hand, the segment of actigraphy systems is poised to hold the most lucrative opportunities in the market during the forecast period.

Increasing Inclination toward Customized Comfortable Devices to Bolster Demand for PAP Devices

On the basis of therapeutic devices, the segment of positive airway pressure (PAP) devices accounted for a significant share in the past. On the other hand, the segment of oral appliances is poised to exhibit the greatest growth rate of 11.80% during the forecast period. This is owing to the growing inclination toward comfortable custom made devices and the launch of economical devices with enhanced comfort levels.

Geographically, the global sleep apnea diagnostic and therapeutic devices market is led by the region of North America and the North America sleep apnea diagnostic and therapeutic devices market is predicted to touch 2,518.4 mn by 2019. Europe trailed North America and held the second position in the market. The reasons for the superiority of these two regions include the ongoing technological advances and the growing acceptance of cutting-edge therapeutics and diagnostic platforms here.

New Innovative Technologies to Shift Market to High Gear

The ongoing rise in the count of patients suffering from sleep apnea globally is a key factor boosting the growth of the market. In addition, sleep apnea is extremely prevalent in obese individuals owing to their airways becoming blocked or obstructed because of enlarged tongue and excessive fat around their neck. Hence, the growing occurrence of obesity will provide impetus to the development of the global sleep apnea diagnostic and therapeutic devices market. “The introduction of new technologies in both treatment and diagnosis will positively impact the growth of the market”, says a TMR analyst.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=588

On the other hand, factors such as absence of patient compliance owing to handling difficulties and discomfort experienced by patients while using sleep apnea devices may impede the growth of this market. Nonetheless, a number of companies are putting in efforts for developing easy to utilize and compact, yet effective devices in this market, thus bringing in new opportunities in the market and bolstering market growth, states a TMR analyst.

This information is based on the findings of a report published by Transparency Market Research titled, “Sleep Apnea Diagnostic and Therapeutic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

Microfluidic Device Systems Market in North America to Grow at Striking 21.70% CAGR from 2013 to 2019

Transparency Market Research has recently published a new research report that evaluates the overall global microfluidic device systems market and provides a trajectory of the market. The research report, titled “Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” studies microfluidic devices system as an evolving scientific field that has myriad analytical applications and a huge commercial potential.

It is a multidisciplinary field that uses engineering, chemistry, physics, nanotechnology, biochemistry, and biotechnology with practical solutions that use low fluid volumes achieve automation, multiplexing, and high-throughput screening. These devices are used in areas of cell biology research, medicine, and protein crystallization. The primary goal of these devices is to bring in efficiency and improve treatments.

According to the research report, the global microfluidic device systems market was valued at US$1.5 bn in 2013 and is expected to reach US$5.2 bn by 2019, rising at a CAGR of 22.80% between 2013 and 2019. The key factor propelling the global microfluidic device systems market is the high demand for these systems in chip miniaturization, proteomics, and genomics. Furthermore, the growing demand from the point-of-care testing segment will also boost this market.

The global microfluidic device systems market has been segmented on the basis of material, industry, application, and geography. The materials available in this market are glass, silicon, and polymer. The industries using these systems are pharmaceuticals, medical devices, and in-vitro diagnostics. On the basis of application this market is segmented into point of care testing, pharmaceutical and life science research, drug delivery, analytical devices, clinical and veterinary diagnostics, and environment and industrial. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Of all the industries, the in-vitro diagnostics industry is the largest user of microfluidic device systems. This industrial segment was valued at US$949.6 mn in 2013 and is likely to reach US$3.3 bn in 2019, surging at a CAGR of 23.20% 2013 and 2019. Meanwhile, the medical devices segment will also play a vital role in the changing application dynamics of the global microfluidic device systems market.

Out of all the applications, the veterinary and clinical diagnostics held the largest share in the market. However, analysts predict that point of care testing segment will show a remarkable growth rate in the global microfluidic device systems market in the foreseeable future. The North America microfluidic device system market holds a dominant position as it was valued at US$644.5 mn in 2013 and is expected to reach US$2 bn in 2019, expanding at a CAGR of 21.70% from 2013 to 2019.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1561

Some of the key players in the global microfluidic device systems market are Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Bio-Rad Laboratories, Agilent Technologies, Fluidigm Corporation, Becton Dickinson and Company, and Johnson & Johnson. The research report profiles these players and provides a complete analysis of the competitive landscape of the overall market. Furthermore, the report also presents a fair case of regulatory framework governing the overall market. The research and development activities, branding ideas, business and marketing strategies, and strategic mergers and acquisitions of these players have also been mentioned in this extensive research report.

Medical Disposables Market: Industry Players Shifting Focus towards Developing Economies

Disposal of medical waste has become a daunting task for healthcare practitioners as the need for sustainable disposal solutions has become a pressing one. This has brought the packaging materials being used for storing medical devices into the spotlight. To reduce the impact of medical wastes on the environment and to minimize the chances of cross-contamination, players operating in the global medical disposables market are focusing on thoughtful product engineering and design. The key players in the global market are Johnson & Johnson, Dickinson, and Company, Becton, 3M Company, and Covidien plc.

Download Free exclusive Sample of this report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=388

Q. What are the recent developments in the global medical disposables market?

A. In June 2016, Husky Injection Molding Systems won the Process Innovation Supplier award from Becton Dickinson. The award was in recognition of the company’s effort towards promoting Becton Dickinson's vision to improve customer satisfaction levels while meeting the needs to develop effective solutions for disposal of medical wastes. Husky’s Medical Business Unit stated that it intends to reduce the amount of waste and the cut down on the capital expenses that are lost in managing the waste materials. The company has also shown a promise of improving productivity and optimizing the floor space.

According to the research report the global medical disposables market is anticipated to be worth US$193.9 bn by the end of 2018 rising from US$144.6 bn in 2011, as the market progresses at a CAGR of 4.30% CAGR between 2012 and 2018.

Q. Why will certain end users benefit during the forecast period?

A. The end users in the global medical disposables market are emergency care units, home healthcare facilities, outpatient facilities, physician offices, and hospitals. Of these, the hospitals are the prime end users due to the growing number of patient admissions, emergency visits, and high frequency of surgical procedures. However, the home healthcare segment is anticipated to be fastest-growing one in the near future as the healthcare sector is focusing on reducing the number of readmissions, hospital stays, and providing preventive medical assistance to the elderly. This trend is predominantly being seen in the U.S.

Q. Which region besides North America will witness a significant growth rate?

A. In terms of geography, the global disposables market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these four regions, the North America medical disposables market is anticipated to soar in the coming years, primarily due to a dependable healthcare infrastructure. According to the extensive research report, North America held a share of about 70% in the overall market in 2011. The region is expected to witness a remarkable growth rate due to a growing awareness about healthcare issues.

Asia Pacific is also anticipated to be an emerging region in the global medical disposables market due to a large pool of patients, rising expenditure on healthcare, and improving disposable incomes.

The high prevalence of diseases, growing pool of geriatrics, and increasing demand for healthcare are all contributing towards the growth of the global medical disposables market. Analysts predict that growing volumes of patient admissions and the need for diagnostics will continue to propel the demand for medical disposables in the coming years. However, tough approval norms set by FDA and GMP are expected to restrain the market in the forecast years, predict analysts.

Microfluidic Device Systems Market in North America to Grow at Striking 21.70% CAGR from 2013 to 2019

There has been a recent release of a new report on the global microfluidic device systems market by Transparency Market Research (TMR). The report suggests that the global microfluidic device market is estimated to grow at a CAGR of 22.8% during the period of 2013 to 2019. The market, which was valued at US$1.5 bn in 2013, will reach US$5.2 bn in 2019.The report, which is titled “Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” provides a comprehensive study on the analysis of the microfluidic device market for the period from 2014 to 2019, wherein 2013 is considered as the base year for calculation. The report contains data related to the current market dynamics, trends, market drivers, restraints, and also the strategic developments propelling the global microfluidic device systems market.

The report states that the rising demand for microfluidic devices in proteomics and genomics, point of care testing, and miniaturization of chips are the chief driving forces behind the microfluidic device systems market’s growth. Another factor that could fuel the growth of the microfluidic device systems market is a change in the material mix, which would provide an opportunity to new market entrants. Conversely, strict regulations and standards for global affiliation of medical devices as well as high performance and consistency in quality of the devices are some of the factors limiting the growth of the microfluidic device systems market. Manufacturing issues such as surface chemistry and geometrical issues also account for the challenges faced by the microfluidic device systems market.

The report categorizes the global market for microfluidic device systems chiefly on the basis of four criteria: geography, industry, application, and materials used in the manufacturing process of microfluidic devices.

On the basis of application, the market for microfluidic devices is segmented into pharmaceutical and life sciences research, point of care testing, environment and industrial, clinical and veterinary diagnostics, and drug delivery. Of these, the largest segment of the microfluidic devices market is the veterinary and clinical diagnostic application segment.

Request free Sample pages of premium Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1561

Geographically, the microfluidic devices market is segmented into Asia, North America and Europe, wherein North America dominates the global microfluidic devices market, while Asia is a rapidly developing region for the microfluidic devices market.

On the basis of industry, the microfluidic devices market is segmented into in- vitro diagnostics, pharmaceuticals, and medical devices. Among these, in-vitro diagnostics is the largest industry and is estimated to reach US$3.3 bn in 2019.

The report profiles some of the prominent companies such as Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Becton Dickinson and Company, Agilent Technologies, Fluidigm Corporation, Bio-Rad Laboratories, and Johnson & Johnson, which are key players in the microfluidic devices market.

The market for microfluidics devices can be expected to rise as microfluidics is an evolving field with a huge potential commercially. With applications in various fields such as cell biology research, protein crystallization, and medicine, microfluidics will remain in the market due to its efficacy in the field of treatment.

Global Microfluidic Device System Market to be Driven by Surging Demand from Proteomics and Genomics

Drug screening, micro fuel cells, chemical micro reactor, sugar testers, and microprocessor cooling are a few of the key areas which extensively use microfluidic devices. In 2013, the global microfluidic device system market had a market value of US$1531.2 million. Owing to factors such as increasing application of microfluidic device systems in the areas of proteomics and genomics, this market is anticipated to reach US$5246.4 million by 2019, growing at a CAGR of 22.8% from 2013 to 2019. Microfluidic devices are a nascent scientific field of study with enormous commercial and analytical applications.

The robust growth of the global microfluidic device system market can be attributed to key factors such as a high demand for point of care testing, miniaturization of chips, and changes in material mix. Miniaturization of chips leads to lower costs of testing, and changing material mix leads to newer opportunities for new market entrants.

Demand for Point of Care Testing to Propel Overall Demand from Microfluidics Device System Market

The global microfluidic device system market is segmented on the basis of material type, application, industry, and geography. On the basis of material type, this market is segmented into polymer, silicon, and glass. Based on application, the global microfluidic device system market is classified into environment and industry, clinical and veterinary diagnostics, drug delivery, point of care testing, analytical devices, and pharmaceutical and life science research. Within the application segment, clinical and veterinary diagnostics leads the overall microfluidic device system market.

Microfluidic device systems are also applied in the areas of protein crystallization, cell biology research, and medicine. Latest healthcare trends, which include home healthcare, reveal that point of care testing is a highly sought-after delivery method for healthcare services. In the area of genomics, microfluidic device systems ensure higher test speed, lower consumption of reagents, and greater efficacy.

On the basis of industry, the microfluidic device system market is segmented into medical devices, in-vitro diagnostics, and pharmaceuticals. The in-vitro diagnostics segment holds the largest share within the industry segmentation of the global microfluidic device system market.

Asia to Lead Microfluidics Device System Market Due to Growing Spread of Healthcare Infrastructure

Geographically, the global microfluidic device system market is segmented into Asia, North America, Europe, and Rest of the World. North America leads the overall microfluidic device system market in terms of both revenue and volume. Some of the prominent market drivers for the North America microfluidic device system market include greater technological development, high incidence of lifestyle diseases, a rapidly growing geriatric population, and greater health awareness.

In 2013, this regional market was worth US$644.5 million and is anticipated to report a value of US$2095.5 million by 2019. The Asia microfluidic device system market is expanding rapidly owing to significant growth of the industry and application segments of medical devices and point of care testing, respectively.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1561

Reduced Side Effects and Higher Efficacy Drives Demand for Microfluidic Device Systems

Microfluidics technology ensures greater efficacy of treatments and reduction of side effects. High demand for miniaturization of pharma and medical devices is a prominent factor that drives the demand for microfluidics technology. Ongoing trends also indicate that this technology is increasingly being applied in the area of micro engineering solutions.

Growing at a 23.2% CAGR, the in-vitro diagnostics segment is anticipated to reach a market value of US$3317.4 million by 2019 from US$949.6 million in 2013.

The overall microfluidic device system market is characterized by a number of product innovations and partnerships between major market players. Some of the key factors that hamper the growth of the global microfluidic device system market are strict regulatory standards and issues pertaining to geometrical and surface chemistry.

The key companies operating in the microfluidic device system market are Becton, Dickinson and Company, Johnson & Johnson, Micronit Microfluidics, Dolomite Centre, RainDance Technologies, Bio-Rad Laboratories, Agilent Technologies Inc., Abbott Laboratories, and Roche Diagnostics.

Hyaluronic Acid Market to Register Impressive CAGR, Driven by Increasing Demand for Anti-Aging Procedures

Hyaluronic acid is a crucial part of the human skin and has a beneficial effect on the durability of skin. It is also called hyaluronan or hyaluronate and is naturally present in connective, neural, and epithelial tissues. The production of hyaluronic acid slows down with aging, aiding the degradation of skin cells. The rising awareness about this natural process has led to high demand for hyaluronic acid products of various types. According to Transparency Market Research, the global hyaluronic acid products market is expected to rise to a valuation of US$9.8 bn by 2019.

Here are the primary driving factors propelling the global hyaluronic acid products market:

Increasing Demand for Anti-aging Products: The global population is keener than ever to maintain a youthful appearance, leading to steady demand for various skincare products. The rising usage of hyaluronic acid, due to its biocompatibility, has resulted in high demand from the global hyaluronic acid products market.

Rising Awareness Regarding Risks of Synthetic Skincare Products: The USP of hyaluronic acid has always been the fact that it is not only naturally found but also naturally produced within the human body. This renders it safe for skincare applications. Since most artificial skincare compounds can have adverse effects on the skin, the usage of hyaluronic acid products is on the rise, boosting the global market.

High Demand for Minimally Invasive Procedures: The convenience of hyaluronic acid products, which are just as effective when applied topically as when injected into the body, is another major factor propelling the global hyaluronic acid products market. Instead of injections of compounds boosting the appearance of skin, such as botox, the usage of hyaluronic acid products to boost the internal system maintaining the health of skin is rising.

Request for Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2033

Rising Living Standards in Asia Pacific to Boost Global Hyaluronic Acid Products Market

The regional market for hyaluronic acid products in Asia Pacific was the third largest regional segment of the global hyaluronic acid products market. This region, however, is expected to be the fastest growing market for hyaluronic acid products in the coming years. Along with other developing countries in Rest of the World, Asia Pacific countries are expected to witness high rates of development of medical infrastructure in the coming years. This will directly propel the global hyaluronic acid products market, as treatments involving hyaluronic acid products will be more accessible to the common man.

In addition to this, the rising living standards in dynamic countries such as India, China, Thailand, Singapore, etc. will also benefit the hyaluronic acid products market. The increasing awareness about and demand for maintaining a youthful appearance as a result of the increased living standards will propel the Asia Pacific hyaluronic acid products market at a steady pace in the coming years.

Teleradiology Market Responds to Impressive Progress in Medicine and Healthcare

Transparency Market Research has published a new report on the global teleradiology market. As per the report, the global teleradiology market is predicted to expand at a 22.30% CAGR during the period between 2013 and 2019. The report, titled ‘Teleradiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019,’ states that the global teleradiology market stood at US$0.9 bn in 2012 and is expected to reach US$3.8 bn by 2019 owing to factors such as technological advancements and the introduction of mhealth services.

Teleradiology consists of the electronic transmission of radiological images from a particular location to another in a digital format using the internet. Image transfer is primarily carried out from the sender’s end to a secondary location for either consultation or an official diagnosis. Consistent developments and advancements in digital imaging technology have favored the acceptance of teleradiology technologies. The increasing acceptance of social media platforms and the internet in general is further expected to augment the use of teleradiology practices across the globe.

Continuous upgradation of radiology information systems (RIS) and picture archiving and communication systems (PACS) is expected to enhance the teleradiology process. The global teleradiology market is segmented on the basis of geography and modality. Based on modality, the global teleradiology market is classified into x-ray, ultrasound, computed tomography (CT), nuclear imaging, and magnetic resonance imaging (MRI). The x-ray teleradiology segment is expected to register new growth opportunities due to increased awareness, low costs compared to other modalities, and increasing digitalization.

Ultrasound imaging technology, popularly used in diagnosing women’s ailments, is majorly employed to track and visualize development stages of a fetus at the time of pregnancy. Compared with x-rays, ultrasound imaging technology is more beneficial due to its minimally invasive nature. The acceptance of MRI imaging technology is still at a nascent stage due to the high costs of the equipment and lack of technical expertise.

Based on geography, the global teleradiology market is divided into Europe, Asia Pacific, North America, and Rest of the World. In 2012, the global teleradiology market was led by North America, which held a revenue share of more than 33%. The presence of well-equipped healthcare institutions and hospitals and the increasing use of high-bandwidth internet are predicted to propel the North America teleradiology market in the years to come.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1132

The Asia Pacific teleradiology market is expected to register considerable growth in the coming few years due to ongoing developments in healthcare informatics and medical imaging platforms. However, lack of image data security is expected to hamper the growth of the global teleradiology market through the forecast period.

Agfa-Gevaert N.V., American TeleCare, Inc., Cybernet Systems Corporation, ONRAD, Inc., Radisphere National Radiology Group, Inc., Sectra AB, StatRad, Teleradiology Solutions, and Virtual Radiologic (vRad) are some of the leading companies in the global teleradiology market. The entry of new companies is expected to make the global teleradiology market highly competitive in the coming years.

Advancements and Innovations Driving the Hospital Stretchers Market

A report, titled “Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” from Transparency Market Research (TMR) provides a 360-degree view of the market. According to the report, the global hospital stretchers market is projected to expand at a CAGR of 3.90% during the forecast period from 2013 to 2019.

In 2012, the global hospital stretchers market was estimated at US$1.3 bn and by 2019, the market is projected to be worth US$1.7 bn. The global hospital stretchers market is driven by the rising prevalence of chronic conditions. Furthermore, the expanding geriatric and obese populations will also propel the global hospital stretchers market. The global hospital stretchers market will also benefit from the growing number of hospital stays.

Moreover, the increasing number of day care surgeries will also drive the global hospital stretchers market. The global hospital stretchers market will also benefit from the increasing average lifespan of hospital stretchers, which ranges from 7 to 10 years, and the growing presence of refurbished equipment. On the other hand, the global hospital stretchers market will be hampered by the high cost of specialized stretchers.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1518

On the basis of product type, the global hospital stretchers market is divided into radiographic stretchers, bariatric stretchers, adjustable stretchers, fixed-height stretchers, and others. The bariatric stretchers segment is projected to expand swiftly during the forecast period at a CAGR of 5.90%. This segment is driven by the rising obese population. As obese patients need to be carried to hospitals and healthcare centers with ease, the demand for bariatric stretchers has increased significantly due to their ability to carry very heavy weights.

According to technology, the global hospital stretchers market is bifurcated into motorized and non-motorized hospital stretchers. Application-wise, the global hospital stretchers market is classified into radiology, pediatric surgery, day care surgery, emergencies, and intra-hospital transport.

By region, the global hospital stretchers market is divided into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America dominates the global hospital stretchers market due to the presence of a lot of manufacturers in this region. Furthermore, this region benefits from the rise in the population affected with chronic diseases and this region’s cutting-edge medical infrastructure.

Nevertheless, it is Asia Pacific that is the most favorable market in the global hospital stretchers market, due to the expanding medical tourism sector in this region. The medical tourism market is expanding rapidly in countries such as India and Singapore.

The research study recommends that companies must focus on developing innovative and cost-effective hospital stretchers. Players in the global hospital stretchers market, particularly small-scale industries, will also benefit by expanding their product portfolio. Moreover, focusing on the emerging markets of Latin America and Asia Pacific will also benefit companies operating in the global hospital stretchers market. Some of the leading companies operating in the global hospital stretchers market are Stryker Corporation, Givas, Gendron, Fu Shun Hsing Technology, and Anetic Aid Limited.

Global Medical Fiber Optics Market to Exhibit 7.60% CAGR Driven by Increased Healthcare Investment

The rising use of medical fiber optics in minimally invasive surgeries has been augmenting the demand from the global medical fiber optics market. In its report, titled “Medical Fiber Optics Market- Global Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019,” Transparency Market Research provides a holistic overview of the global medical fiber market and presents insights into the growth drivers and restraints impacting its growth trajectory.

The report pegs the overall value of the global medical fiber optics market at US$863.1 mn in 2013. By the end of 2019, the market is expected to reach an overall valuation of US$1.3 bn. If these figures hold true, the global medical fiber optics market will exhibit a CAGR of 7.60% between 2013 and 2019.“The market for medical fiber optics has been substantially capitalizing on technical advancements in medical devices, resulting in their miniaturization,” said a lead TMR analyst. “The market is also gaining impetus from the rising demand for advanced technologies and rapid development in fiber technology,” he added.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=546

Despite exhibiting a positive growth trajectory, stringent regulations to ensure high standards and the risk linked with the high intensity of fiber optic lights are some crucial challenges inhibiting the global market for medical fiber optics. Nevertheless, improvements in healthcare infrastructure and medical standards, together with growing awareness about the diverse applications of fiber optics, will enable the market to capitalize on lucrative opportunities in the near future.

The report studies the global medical fiber optics market on two fronts, namely application and regional distribution. Based on application, the global medical fiber optics market is segmented into endoscopes, fiberoptic surgical lights, fiberoptics, fiberoptic sensors, fiberoptic dental lights, and others. Regionally, the market is broadly classified into Asia Pacific, Europe, North America, and Rest of the World.

Among the segments based on applications, the endoscopes segment emerged as the dominant player in 2013, with a valuation of US$339.8 mn. The market for endoscopes is likely to expand at a positive CAGR of 8.10% during the report’s forecast period and reach US$543 mn by 2019.

Regionally, the global medical fiber optics market is dominated by North America, since the region boasts high standards and sophisticated healthcare and medical infrastructure. Apart from this, increasing demand for minimally invasive surgeries from the region also boosts the North America market for medical fiber optics, which through the forecast period will maintain its lead in the global medical fiber optics market.

To present a comprehensive overview, the report profiles some of the leading players operating in the market such as Timbercon Inc., IPG Photonics, Coherent Inc., Schott, Rofin, Leoni AG, Vitalcor Inc., Trumph, Sunoptic Technologies, and American Medical System. Additionally, the report states that during its forecast period, Asia Pacific will exhibit the fastest CAGR as one of the regional markets for medical fiber optics.

Ambulance Services Market to Exhibit Impressive Growth Owing to Rising Number of Accidents

Ambulance services help transport medically injured or ill patients to-and-from hospitals to ensure timely health check-up and treatment by healthcare professionals. These services are availed by patients directly or by hospitals and other organizations. According to an article published in daily newspaper of the U.S., around 17.3 million emergency patient transports occurred in the year 2012 across the world. Thus, increasing number of emergency cases remains one of the major drivers expected to augment the growth of this market. Further, increasing geriatric population and rise in prevalence of chronic diseases such as cancer and diabetes are some other key reasons held responsible for increasing the demand for ambulance services. Favorable reimbursement scenario, entrance of new ambulance service providers globally and increasing home healthcare are also anticipated to drive the market for ambulance services. Hence, on account of aforementioned factors the global market for ambulance services is expected to grow at a CAGR of 8.3% from 2013 to 2019 to reach an estimated value of USD 29,784.4 million in 2019. However, imposition of strict regulation by the Federal Aviation Administration (FAA) for air ambulance may set back the overall growth of ambulance services market.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/ambulance-services-industry.htm

The market for ambulance services has been segmented based on the mode of transport as ground ambulance services, air ambulance services and water ambulance services. Similarly, the market has also been classified on the basis of emergency types such as emergency ambulance services and non-emergency ambulance services. Furthermore, based on equipment types that are installed in an ambulance, the market has been subdivided as advanced life support (ALS) ambulance services and basic life support (BLS) ambulance services. Of these, market for air ambulance services has been estimated to foresee the highest CAGR during the forecast period 2013 to 2019. Growth of this ambulance service is observed due to rising medical tourism in countries such as India, Brazil and Thailand coupled with entrance of large number of players for providing air ambulance services. Also, fees for availing air ambulance services results in high revenue generation.

Further, emergency ambulance services market accounted for the largest share by revenue in 2012 and is also expected to grow at the highest CAGR during the forecast period. ALS ambulance services market among the equipment types is expected to grow at the highest CAGR during the forecast period. Increasing number of emergency cases for which ALS ambulances are utilized extensively will undoubtedly propel the growth of this market. Similarly, shifting trends for utilizing ALS ambulances by hospitals for patients would also augment the growth of this market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2347

Growing Prevalence of Chronic Illnesses to Boost Global Ambulance Services Market

Ambulance services are intrinsic to the overall healthcare industry because they help transport critically ill or injured patients to clinics or hospitals. These services play a major role in ensuring timely health interventions. Patients can either avail these services directly or via hospitals and other organizations. Nearly 17.3 mn emergency patient transports were reported around the world in 2012. This number, however, has increased dramatically in the last few years and is poised to surge exponentially in the near future. The increasing incidence of emergency cases, therefore, remains a major factor accelerating the market for ambulance services. Additionally, the increasing geriatric population and rising prevalence of chronic illnesses such as diabetes and cancer will also aid the market’s growth. Entrance of new ambulance service providers and favorable reimbursement policies in the global healthcare industry will drive the demand for ambulance services in the near future.

On account of the aforementioned factors, the global ambulance services market is expected to exhibit a positive CAGR of 8.30% between 2013 and 2019. The market is anticipated to reach US$29.8 bn by the end of 2019. However, the implementation of stringent regulations such as those imposed by the Federal Aviation Administration may act as a setback for the ambulance services market.

Geographically, North America and Europe accounted for the largest share of the global ambulance services market, capturing more than 80% of the global market in 2012. This large market share of these two regions is justified by the presence of huge number of ambulance service providers in these regions. On the other hand during 2013 to 2019, Asia-Pacific region is expected to grow at the highest CAGR. The growth of this region is witnessed due to increasing geriatric population coupled with rising incidences of chronic diseases. The major players operating in the market include Envision Healthcare Corporation, Falck A/S, Rural/Metro Corporation, Air Methods Corporation and Acadian Ambulance Service.

Ambulance Services Market - An Overview of Growth Factors

As healthcare costs skyrocket, consumers are demanding advanced services that ensure convenience of patients and faster remission of illnesses. Quality healthcare is now usually available at lower costs than before for more people than before, a key development brought about by years of medical research. Patients, particularly in developed countries, are increasingly acknowledging this fact and becoming aware of their diverse options. They now seek better healthcare services to get proper value for their money. This has brought about several changes in the most intrinsic healthcare services, ambulance services market being one of them. Furthermore, a part of the push for enhanced ambulance services is also focused on eliminating the chances of hospital readmissions within a shorter period of time.

Read Full Article: http://www.transparencymarketresearch.com/article/ambulance-services-industry.htm

Growing Prevalence of Chronic Illnesses to Boost Global Ambulance Services Market

Ambulance services are intrinsic to the overall healthcare industry because they help transport critically ill or injured patients to clinics or hospitals. These services play a major role in ensuring timely health interventions. Patients can either avail these services directly or via hospitals and other organizations. Nearly 17.3 mn emergency patient transports were reported around the world in 2012. This number, however, has increased dramatically in the last few years and is poised to surge exponentially in the near future. The increasing incidence of emergency cases, therefore, remains a major factor accelerating the market for ambulance services. Additionally, the increasing geriatric population and rising prevalence of chronic illnesses such as diabetes and cancer will also aid the market’s growth. Entrance of new ambulance service providers and favorable reimbursement policies in the global healthcare industry will drive the demand for ambulance services in the near future.

On account of the aforementioned factors, the global ambulance services market is expected to exhibit a positive CAGR of 8.30% between 2013 and 2019. The market is anticipated to reach US$29.8 bn by the end of 2019. However, the implementation of stringent regulations such as those imposed by the Federal Aviation Administration may act as a setback for the ambulance services market.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2347

Entry of New Ambulance Service Providers to Augment Demand from Global Ambulance Services Market

The ambulance services market is segmented on the basis of mode of transport into ground, air, and water ambulance services. The market can also be classified on the basis of emergency type into non-emergency ambulance services and emergency ambulance services. Furthermore, on the basis of equipment type, the market can be segmented into basic life support or BLS ambulance services and advanced life support or ALS ambulance services. Among these segments, the market for air ambulance services is anticipated to exhibit the highest CAGR between 2013 and 2019.

Rising medical tourism in nations such as India, Thailand, and Brazil, together with the emergence of a large number of service provides, will fuel the global market for ambulance services in the near future. Since the cost of offering ambulance services is recompensed by increased revenue generation through it, it is expected that in the near future, the healthcare sector will invest more on research and development initiatives to offer patients the best facilities. This will give a significant boost to the global market for ambulance services.

Browse Full Global Ambulance Services Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/ambulance-services-industry.html

Global Teleradiology Market: Mobile Health Services to Help Market Growth During 2013-2019

The global teleradiology market was worth US$0.92 billion in 2012. It has been predicted that this market will grow at a CAGR of 22.3% from 2013 to 2019, eventually reaching an estimated market value of US$3.78 billion. These projections are provided in a market research report titled Teleradiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019, released by market intelligence firm Transparency Market Research.

The report details the important historical benchmarks of the global teleradiology market and the driving and restraining factors that govern it.

It states the teleradiology segment to be the largest source of revenue for the telehealth technologies industry.

Browse Full Report: http://www.transparencymarketresearch.com/teleradiology-technology-market.html

The teleradiology market involves the technology that deals in the transmission of radiography images from external or remote locations to a strong healthcare establishment in an urban area though software that make use of the Internet. It is the largest and the most mature segment of the telehealth industry and makes use of advanced communication technology in an effort to exchange critical information about a patient in the most efficient manner possible.

The report discusses a comparative overview of the global teleradiology market with respect to the past and the present. Earlier communication systems would convert analog images into digital ones through the use of binary code. The code was then forwarded to a receiving terminal where the data was again converted to analog. Modern methods circumvent this need of conversion thereby saving time and maintaining imaging efficacy.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1132

The report also includes important developments in the global teleradiology market, such as the advent of Radiology Information Systems (RIS) and Picture Archiving and Communication Systems (PACS). These technologies have created a substantial increase in demand of teleradiology services and technologies around the world. The growth of the global teleradiology market along with the increasing use of high bandwidth broadband systems have created a high level of efficiency and assurance across remote channels of the healthcare industry.

The increasing popularity and growing applications in the mobile health segment of the global teleradiology market has allowed radiologists to boost their diagnosis and consultation speeds by letting them do so even while commuting. This has eliminated the requirement of a doctor to access stationary computer terminals for consultations that can be performed using mobile devices.

Browse the full Teleradiology Market (X-ray, Ultrasound, CT, MRI and Nuclear Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/teleradiology-technology-market.htm

The report details the geographic segmentation of the global teleradiology market. It states that North America dominated the global teleradiology market in 2012 with more than 33% of the market share in terms of revenue. This was possible due to the presence of healthcare institutions that possess eligible equipment along with a growing acceptance and knowledge of the public with respect to the technologies.

Global Ambulance Services Market : Increasing Number of Emergency Cases Remains Primary Growth Driver

A recently released report from Transparency Market Research (TMR) forecasts that the global ambulance services market will grow at a CAGR of 8.3% between 2013 and 2019. TMR, a market intelligence firm based in the U.S., states that the global ambulance services market will reach a market value of US$29.78 billion by 2019, from US$17 billion in 2012.The report, titled ‘Ambulance Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, is available for sale on the company website. According to this market research report, rising geriatric population, favorable reimbursement policies, rising incidence of accidents, and increasing prevalence of diseases such as cancer and diabetes are a few of the factors that stimulate the global ambulance services market. The introduction of new ambulances also plays a significant role in determining demand from this market. It is expected that the entry of new ambulance service providers, a favorable and organized reimbursement scenario, and greater home healthcare will propel the demand for ambulance services in the years to come.

Browse Full Report: http://www.transparencymarketresearch.com/ambulance-services-industry.html

This TMR report segments the global ambulance services market on the basis of mode of transport, equipment, type of emergency, and geography. Ground ambulances, water ambulances, and air ambulances are the three modes of transport, with the segment of air ambulances holding the largest share of the market. Equipment-wise, the ambulance services market is categorized into advanced life support and basic life support. The market for advanced life support ambulances is a rapidly growing one, owing to high incidence of emergency cases. In comparison to non-emergency ambulance services, the market for emergency ambulance services is expected to expand at a higher rate in the forecasting horizon.

Get Free Sanple: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2347

Geographically, Europe and North America collectively hold the highest share of the global ambulance services market. The presence of a huge pool of ambulance service providers makes these two markets strong players in the global ambulance services market. However, owing to high incidence of chronic diseases and growing geriatric population, the Asia Pacific market will witness robust growth in the years to come. Growing popularity of medical tourism in Thailand, Brazil, and India will drive the demand in the global ambulance services market during the forecast period.

Browse the full Ambulance Services Market (By Mode of Transport - Ground Ambulance Services, Air Ambulance Services and Water Ambulance Services, By Emergency Type - Emergency Ambulance Services and Non-Emergency Ambulance Services and By Equipment Type - Advance Life Support (ALS) Ambulance Services and Basic Life Support (BLS) Ambulance Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/ambulance-services-industry.htm

Hyaluronic Acid Products Market - Market Dynamics and Opportunities Report by Transparency Market Research

Hyaluronic Acid Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

According to “Hyaluronic Acid Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, a new research report published by Transparency Market Research, the global hyaluronic acid products market valued at US$5.32 billion in 2012, is expected to reach US$9.85 billion by the end of 2019, registering growth at a CAGR of 9.2% during the forecast period from 2013 to 2019.

Browse the full report at
http://www.transparencymarketresearch.com/hyaluronic-acid-products-market.html

Hyaluronic acid is a type of glycosaminoglycan that performs multiple functions in the human body, such as transporting nutrients through the body and retaining water in body tissues. It creates protective and flexible layers around the cell during nascent developments taking place inside the human body and conditions such as wound healing, inflammation, and cancer. Hyaluronic acid is an important component that is present naturally in a human body and is found in high concentrations in fluids around the joints and in the eyes.
A global surge in demand for hyaluronic acid products has been noticed in the recent years.  Factors such as the increasing geriatric population, rising demand for anti-ageing procedures, increased consciousness among patients regarding product side-effects, and rising demand for minimally invasive surgical methods have significantly aided the expansion of the market for hyaluronic acid products globally. 

In this report, we shall find segment-wise analysis of the global hyaluronic acid product market both in terms of product types and applications. In-depth investigation of the market’s performance in individual geographic pockets has been included in the research report as well. Geographically, the research study has segmented the market into North America, Europe, Asia Pacific, and Rest of the World. On the basis of type of product, the market for hyaluronic acid products can be segmented under the categories of single-injection cycle, three-injection cycle, and five-injection cycle. Among these segments, the market for single-injection cycle and three-injection cycle is expected to multiply within the next couple of years due to changing dynamics of the market and high preference among patients in favor of short duration treatments. 

We are currently offering a flat 15% discount on all purchases until end of the March 2015!
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2033

In terms of application, the market for hyaluronic acid can be segmented into osteoarthritis, ophthalmic, dermal fillers, and vesicoureteral reflux (VUR). In the application market, the demand for hyaluronic acid products is the highest in VUR disorders. The demand for hyaluronic acid products from the VUR segment is expected to grow at a CAGR of 12.0% during the forecast period from 2013 to 2019.

According to the report, the major players in the global hyaluronic acid products market include Anika Therapeutics, Inc., Ferring Pharmaceuticals, Inc., Meiji Seika Pharma Co., Ltd., Merz Aesthetics, Inc., Seikagaku Corporation, F. Hoffmann-La Roche Ltd., Galderma S.A., Salix Pharmaceuticals, Inc., Sanofi (Genzyme), Zimmer Holdings, Inc. Allegran Inc., Alcon, Inc., and Smith & Nephew plc.

Download PDF: Hyaluronic Acid Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

About us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse The Market Research Blog :
https://marketsresearchindustry.wordpress.com/